Invention Grant
- Patent Title: PD-1/PD-L1 inhibitors
-
Application No.: US16510647Application Date: 2019-07-12
-
Publication No.: US10774071B2Publication Date: 2020-09-15
- Inventor: Evangelos Aktoudianakis , Aesop Cho , Michael Graupe , Lateshkumar Thakorlal Lad , Paulo A. Machicao Tello , Jonathan William Medley , Samuel E. Metobo , Devan Naduthambi , Barton W. Phillips , Scott Preston Simonovich , Peiyuan Wang , William J. Watkins , Jie Xu , Kin Shing Yang , Christopher Allen Ziebenhaus
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D471/08 ; A61K31/444 ; A61K31/497 ; A61K31/704 ; A61K31/7068 ; A61K39/395 ; A61P31/20
Abstract:
Compounds and methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Public/Granted literature
- US20200017471A1 PD-1/PD-L1 INHIBITORS Public/Granted day:2020-01-16
Information query
